← boardnext 2027-01-15
AZTR
Azitra Inc.distress 7/10 · high distress / dilution risk$0.13-2%today-92% from 52w high
Lead: EGFR Inhibitor-associated Rash
Revenue
pre-revenue
Liquidity
$10M
Runway
0.9 yrs
Shares 1y
-31%
Price & events
-55.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.6%
1D
-3.8%
1W
-39.1%
1M
-40.0%
3M
-55.3%
6M
-91.9%
1Y
-99.6%
2Y
—
5Y
-100.0%
All
Overview
- Market Cap
- $2.07M
- Volume
- 106.75K
- 52 Week Range
- $0.13 – $1.58
- Total Shares
- 16.19M
- Float Shares
- 12.13M
- Short %
- 2.63%
- % Held by Insiders
- 28.42%
- % Held by Institutions
- 6.27%
- RVOL
- 0.00x
- Beta
- -1.21
Pipeline stages · 3 programs
ATR04-484
Preclin›
Ph1›
Ph2›
Ph3›
Filed›
PDUFA›
Approved
ATR-04
Preclin›
Ph1›
Ph2›
Ph3›
Filed›
PDUFA›
Approved
ATR12-351
Preclin›
Ph1›
Ph2›
Ph3›
Filed›
PDUFA›
Approved
Pipeline · 3 trials · 1 upcoming
Catalyst news & presentations · 4
- late 2026Guided 55%readoutATR-COSF · Complete clinical study evaluating effect on appearance of fine lines and wrinklesSEC 8-K
- 2026-03-13warning letterReceived NYSE American non-compliance notice for minimum stockholders' equity.SEC 8-K
- 12:00PM ET on June 17, 2025conferencedata presentationsecondaryPresentation at BIO International Convention discussing ATR12-351 and ATR04-484 trials.SEC 8-K
- 2025-04-24partnershipEntered into a $20 million share purchase agreement with Alumni Capital LP.SEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2025-09-24Maxim GroupBuy
Competitors — EGFR Inhibitor-associated Rash
- none identified
Recent news
- 2026-07-21Azitra Inc. (AZTR) surges over 44% after hours—here's why it's trending - MSN
- 2026-07-21Enterprise value to EBIT forward of Azitra Inc – AMEX:AZTR - TradingView
- 2026-07-21Price to sales forward of Azitra Inc – AMEX:AZTR - TradingView
- 2026-07-21Why are shares of Azitra rising? - MSN
- 2026-07-17Why are shares of Azitra rising? - MSN
- 2026-07-17Enterprise value to revenue forward of Azitra Inc – AMEX:AZTR - TradingView
- 2026-07-16Price to earnings forward of Azitra Inc – AMEX:AZTR - TradingView
- 2026-07-15Azitra, Inc. (NYSE American: AZTR) shows dose-linked skin elasticity gains - Stock Titan
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.